Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Rating of “Hold” by Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have earned a consensus recommendation of “Hold” from the eleven ratings firms that are covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $51.50.

A number of brokerages have recently issued reports on RHHBY. Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target on the stock in a research report on Friday, April 24th. Citigroup began coverage on shares of Roche in a research report on Tuesday, January 27th. They issued a “buy” rating on the stock. Argus upgraded shares of Roche from a “hold” rating to a “buy” rating in a research report on Monday, April 6th. TD Cowen reiterated a “hold” rating on shares of Roche in a research report on Tuesday, February 10th. Finally, Wolfe Research reiterated an “outperform” rating on shares of Roche in a research report on Thursday, February 26th.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of RHHBY. Canopy Partners LLC lifted its position in shares of Roche by 4.9% during the 3rd quarter. Canopy Partners LLC now owns 7,580 shares of the company’s stock valued at $317,000 after acquiring an additional 352 shares during the period. Boston Common Asset Management LLC lifted its position in shares of Roche by 1.9% during the 3rd quarter. Boston Common Asset Management LLC now owns 368,553 shares of the company’s stock valued at $15,049,000 after acquiring an additional 6,720 shares during the period. Oakworth Capital Inc. acquired a new position in shares of Roche during the 3rd quarter valued at $57,000. Sentinel Trust Co. LBA acquired a new position in shares of Roche during the 3rd quarter valued at $878,000. Finally, Altrius Capital Management Inc lifted its position in shares of Roche by 4.0% during the 3rd quarter. Altrius Capital Management Inc now owns 198,278 shares of the company’s stock valued at $8,290,000 after acquiring an additional 7,659 shares during the period.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $51.09 on Friday. Roche has a 52-week low of $37.51 and a 52-week high of $60.85. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38. The company’s 50 day moving average price is $50.70 and its 200-day moving average price is $51.33.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.